GROWTH BUYOUT & VENTURE CAPITAL

Engaged Partnership - A long-term view.
The essentials for transformative growth in life sciences.

 


Latest Investment

Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy. The Company’s lead program, ADP101, is being

News

2020-08-31

FDA Approves XARACOLL® (bupivacaine HCl) Implant, a Non-opioid, Drug-device Treatment Option for Acute Postsurgical Pain Relief for up to 24 Hours Following Open Inguinal Hernia Repair in Adults